LGI1 and Cognitive impairment: We compare those with and without cognitive impairment, quantify the relative effects of AEDs and immunotherapy, address the hypothesis that early immunotherapy administration may prevent progression to cognitive impairment (Irani et al., 2011), and explore potential pathogenic mechanisms of the LGI1 antibodies.